Gurubasavaraj Veeranna Pujar

Dr. Gurubasavaraj Veeranna Pujar

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2022 in Electronics
Verified
Journal Article
Open access
PDF file
MSManisha Singh
Manisha Singh
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
SKSethu Arun Kumar
Sethu Arun Kumar
MBMeduri Bhagyalalitha
Meduri Bhagyalalitha
HAHandattu Shankaranarayana Akshatha
Handattu Shankaranarayana Akshatha
Amir H GandomiAmir H Gandomi
Amir H Gandomi
Tuberculosis (TB) is an infectious disease that has been a major menace to human health globally, causing millions of deaths yearly. Well-timed diagnosis and treatment are an arch to full recovery of the patient. Computer-aided diagnosis (CAD) has been a hopeful choice for TB diagnosis. Many CAD approaches using machine learning have been applied for TB diagnosis, specific to the artificial intelligence (AI) domain, which has led to the resurgence of AI in the medical field. Deep learning (DL), a major branch of AI, provides bigger room for diagnosing deadly TB disease. This review is focused on the limitations of conventional TB diagnostics and a broad description of various machine learning algorithms and their applications in TB diagnosis. Furthermore, various deep learning methods integrated with other systems such as neuro-fuzzy logic, genetic algorithm, and artificial immune systems are discussed. Finally, multiple state-of-the-art tools such as CAD4TB, Lunit INSIGHT, qXR, and InferRead DR Chest are summarized to view AI-assisted future aspects in TB diagnosis.

1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KKK. Mohan Krishna
K. Mohan Krishna
BIBharathkumar Inturi
Bharathkumar Inturi
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
MPMadhusudan N Purohit
Madhusudan N Purohit
GVG.S. Vijaykumar
G.S. Vijaykumar

23 December 2021 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SKSethu Arun Kumar
Sethu Arun Kumar
TKThirumoorthy Durai Ananda Kumar
Thirumoorthy Durai Ananda Kumar
Narasimha BeerakaNarasimha Beeraka
Narasimha Beeraka
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
MSManisha Singh
Manisha Singh
MBMeduri Bhagyalalitha
Meduri Bhagyalalitha
Predicting novel small molecule bioactivities for the target deconvolution, hit-to-lead optimization in drug discovery research, requires molecular representation. Previous reports have demonstrate...

1 October 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BMBhagyalalitha Meduri
Bhagyalalitha Meduri
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
TKT. Durai Ananda Kumar
T. Durai Ananda Kumar
HAH.S. Akshatha
H.S. Akshatha
ASArun Kumar Sethu
Arun Kumar Sethu
BMBijo Mathew
Bijo Mathew

1 October 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAkshatha H. S
Akshatha H. S
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
ASArun Kumar Sethu
Arun Kumar Sethu
MBMeduri Bhagyalalitha
Meduri Bhagyalalitha
MSManisha Singh
Manisha Singh

24 October 2016 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
BIBharathkumar Inturi
Bharathkumar Inturi
GPGurubasavaraj Veeranna Pujar
Gurubasavaraj Veeranna Pujar
MPMadhusudhan N. Purohit
Madhusudhan N. Purohit